InvestorsObserver
×
News Home

Emyria thrilled with new collaboration for MDMA-assisted PTSD therapy

Wednesday, March 08, 2023 03:30 PM | TheNewsWire via QuoteMedia

Mentioned in this article

Emyria thrilled with new collaboration for MDMA-assisted PTSD therapy

(NewsDirect)

Emyria Ltd (ASX:EMD) MD Michael Winlo tells Proactive the company will collaborate with The Pax Centre (PAX) to develop a scalable care program for the safe provision of MDMA-assisted therapy for patients with treatment-resistant PTSD. This collaboration with Australia’s leading multidisciplinary, psychiatrist-led clinical service specialising in complex trauma treatment, feeds into EMD’s long-term goal to establish a network of trained therapists and psychiatrists to provide MDMA-assisted therapy.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

Jonathan@proactiveinvestors.com

Copyright (c) 2023 TheNewswire - All rights reserved.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App